Early and successful combination antiretroviral therapy normalizes survival time in patients coinfected with human immunodeficiency virus and human T-cell …

C Brites, F Miranda, E Luz… - Clinical Infectious Diseases, 2020 - academic.oup.com
Background Coinfection with human T-cell lymphotrophic virus type 1 (HTLV-1) is
associated with shorter survival for adults and children infected with human …
被引用次数：12 相关文章

Early and Successful Combination Antiretroviral Therapy Normalizes Survival Time in Patients Coinfected With Human Immunodeficiency Virus and Human T-cell …

C Brites, F Miranda, E Luz… - Clinical Infectious Diseases, 2020 - academic.oup.com
Background Coinfection with human T-cell lymphotrophic virus type 1 (HTLV-1) is
associated with shorter survival for adults and children infected with human …

Early and Successful Combination Antiretroviral Therapy Normalizes Survival Time in Patients Coinfected With Human Immunodeficiency Virus and Human T-cell …

C Brites, F Miranda, E Luz… - Clinical Infectious …, 2020 - search.ebscohost.com
Background Coinfection with human T-cell lymphotrophic virus type 1 (HTLV-1) is
associated with shorter survival for adults and children infected with human …
[PDF] academia.edu

[PDF][PDF] Early and Successful Combination Antiretroviral Therapy Normalizes Survival Time in Patients Coinfected With Human Immunodeficiency Virus and Human T …

C Brites, F Miranda, E Luz, EM Netto - Clinical Infectious Diseases, 2020 - academia.edu
Background. Coinfection with human T-cell lymphotrophic virus type 1 (HTLV-1) is
associated with shorter survival for adults and children infected with human …

Early and Successful Combination Antiretroviral Therapy Normalizes Survival Time in Patients Coinfected With Human Immunodeficiency Virus and Human T-cell …

C Brites, F Miranda, E Luz, EM Netto - Clinical Infectious Diseases …, 2020 - europepmc.org
Background Coinfection with human T-cell lymphotrophic virus type 1 (HTLV-1) is
associated with shorter survival for adults and children infected with human …

Early and successful combination antiretroviral therapy normalizes survival time in patients coinfected with human immunodeficiency virus and human T-cell …

C Brites, F Miranda, E Luz, EM Netto - 2020 - cabidigitallibrary.org
Background: Coinfection with human T-cell lymphotrophic virus type 1 (HTLV-1) is
associated with shorter survival for adults and children infected with human …

Early and Successful Combination Antiretroviral Therapy Normalizes Survival Time in Patients Coinfected With Human Immunodeficiency Virus and Human T-cell …

C Brites, F Miranda, E Luz… - … infectious diseases: an …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Coinfection with human T-cell lymphotrophic virus type 1 (HTLV-1) is
associated with shorter survival for adults and children infected with human …
[PDF] academia.edu

[PDF][PDF] Early and Successful Combination Antiretroviral Therapy Normalizes Survival Time in Patients Coinfected With Human Immunodeficiency Virus and Human T …

C Brites, F Miranda, E Luz, EM Netto - Clinical Infectious Diseases, 2020 - academia.edu
Background. Coinfection with human T-cell lymphotrophic virus type 1 (HTLV-1) is
associated with shorter survival for adults and children infected with human …